X4 Pharmaceuticals (XFOR) Tops Q3 EPS by 14c
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.01), $0.14 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.01), $0.14 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.